<akomaNtoso xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"
            xmlns:fmx="http://formex.publications.europa.eu/schema/formex-05.21-20110601.xd"
            xmlns:leos="urn:eu:europa:ec:leos"
            xmlns:xs="http://www.w3.org/2001/XMLSchema">
   <bill name="">
      <meta xmlns:fn="http://www.w3.org/2005/xpath-functions">
         <identification source="~COM">
            <FRBRWork>
               <FRBRthis value=""/>
               <FRBRuri value=""/>
               <FRBRdate date="2999-01-01" name=""/>
               <FRBRauthor href=""/>
               <FRBRcountry value=""/>
            </FRBRWork>
            <FRBRExpression>
               <FRBRthis value=""/>
               <FRBRuri value=""/>
               <FRBRdate date="2999-01-01" name=""/>
               <FRBRauthor href=""/>
               <FRBRlanguage language="eng"/>
            </FRBRExpression>
            <FRBRManifestation>
               <FRBRthis value=""/>
               <FRBRuri value=""/>
               <FRBRdate date="2999-01-01" name=""/>
               <FRBRauthor href=""/>
            </FRBRManifestation>
         </identification>
      </meta>
      <preface>
         <longTitle>
            <p>
               <docStage/>
               <docType>COMMISSION REGULATION (EU) 2017/1413</docType>of 3 August 2017<docPurpose>amending Annex IV to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products</docPurpose>
            </p>
         </longTitle>
         <container name="EEArelevance">
            <p>(Text with EEA relevance)</p>
         </container>
      </preface>
      <preamble>
         <formula name="actingEntity">
            <p>THE EUROPEAN COMMISSION,</p>
         </formula>
         <citations>
            <citation>
               <p>Having regard to the Treaty on the Functioning of the European Union,</p>
            </citation>
            <citation>
               <p>Having regard to Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products<authorialNote placement="bottom" marker="1">
                     <p>OJ L 342, 22.12.2009, p. 59.</p>
                  </authorialNote>, and in particular Article 31(1) thereof,</p>
            </citation>
         </citations>
         <recitals xml:id="recs_d312e71">
            <intro>
               <p>Whereas:</p>
            </intro>
            <recital xml:id="rec_d312e74">
               <num>(1)</num>
               <p>Zinc oxide is authorised as a colorant in cosmetic products under entry 144 of Annex IV to Regulation (EC) No 1223/2009.</p>
            </recital>
            <recital xml:id="rec_d312e80">
               <num>(2)</num>
               <p>In its opinion of 18 September 2012<authorialNote placement="bottom" marker="2">
                     <p>SCCS/1489/12 Revision of 11 December 2012, http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_103.pdf</p>
                  </authorialNote>, which was revised in 23 September 2014<authorialNote placement="bottom" marker="3">
                     <p>SCCS/1539/14 Revision of 25 June 2015, http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_163.pdf</p>
                  </authorialNote>, the Scientific Committee on Consumer Safety (SCCS) concluded that the use of zinc oxide is safe when used as colorant, in its uncoated non-nano form, in cosmetics for dermal application. However, the SCCS also considered that in view of the lung inflammation induced by zinc oxide particles after inhalation, the use of zinc oxide in cosmetic products that may result in exposure of the consumer&apos;s lungs to zinc oxide by inhalation was of concern.</p>
            </recital>
            <recital xml:id="rec_d312e104">
               <num>(3)</num>
               <p>In light of the SCCS opinions, the use of zinc oxide as a colorant, in its uncoated non-nano form, in cosmetic products should be restricted to those applications which may not lead to exposure of the end-user&apos;s lungs by inhalation.</p>
            </recital>
            <recital xml:id="rec_d312e110">
               <num>(4)</num>
               <p>Annex IV to Regulation (EC) No 1223/2009 should therefore be amended accordingly.</p>
            </recital>
            <recital xml:id="rec_d312e116">
               <num>(5)</num>
               <p>The industry should be allowed a reasonable period of time to make the necessary adjustments to product formulations in view of their placing on the market and for the withdrawal of non-compliant products from the market.</p>
            </recital>
            <recital xml:id="rec_d312e122">
               <num>(6)</num>
               <p>The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Cosmetic Products,</p>
            </recital>
         </recitals>
         <formula name="enactingFormula">
            <p>HAS ADOPTED THIS REGULATION:</p>
         </formula>
      </preamble>
      <body>
         <article xml:id="art_d312e131">
            <num>Article 1</num>
            <heading/>
            <paragraph>
               <content>
                  <p>Annex IV to Regulation (EC) No 1223/2009 is amended in accordance with the Annex to this Regulation.</p>
               </content>
            </paragraph>
         </article>
         <article xml:id="art_d312e137">
            <num>Article 2</num>
            <heading/>
            <paragraph>
               <content>
                  <p>From 24 February 2018 only cosmetic products which comply with this Regulation shall be placed on the Union market.</p>
               </content>
            </paragraph>
            <paragraph>
               <content>
                  <p>From 24 May 2018 only cosmetic products which comply with this Regulation shall be made available on the Union market.</p>
               </content>
            </paragraph>
         </article>
         <article xml:id="art_d312e150">
            <num>Article 3</num>
            <heading/>
            <paragraph>
               <content>
                  <p>This Regulation shall enter into force on the twentieth day following that of its publication in the <i>Official Journal of the European Union</i>.</p>
               </content>
            </paragraph>
         </article>
         <clause>
            <content>
               <p>This Regulation shall be binding in its entirety and directly applicable in all Member States.</p>
            </content>
         </clause>
      </body>
      <conclusions>
         <p>Done at Brussels, 3 August 2017.</p>
         <block name="signatory">
            <signature>
               <organization refersTo="">For the Commission</organization>
               <role refersTo="">The President</role>
               <person refersTo="">Jean-Claude JUNCKER</person>
            </signature>
         </block>
      </conclusions>
   </bill>
</akomaNtoso>
